Canaan Partners XI LLC, 10% Owner at Day One Biopharmaceuticals, Inc. (DAWN), sold 532,734 shares at $20.57 ($11.0M) on 2022-09-19, disclosed to the SEC on 2022-09-20.
Open-market sale of $11.0M DAWN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.53 | 111,585 | $2.4M | 21.8% |
| 2 | $21.53 | 111,585 | $2.4M | 21.8% |
| 3 | $22.04 | 3,722 | $82K | 0.7% |
| 4 | $22.04 | 3,722 | $82K | 0.7% |
| 5 | $20.57 | 76,725 | $1.6M | 14.3% |
| 6 | $20.57 | 76,725 |
| $1.6M |
| 14.3% |
| 7 | $19.50 | 146,404 | $2.9M | 25.9% |
| 8 | $20.10 | 2,266 | $46K | 0.4% |
| Total | $20.70 avg | 532,734 | $11.0M | 100% |
| Filing → |